Nova is a world leader in the development and manufacture of whole blood, point-of-care and critical care analyzers, as well as instruments for cell culture monitoring in the biotechnology market. Nova uses biosensor technology in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for stat measurement of over 22 analytes. Nova employs over 1,400 people worldwide and has wholly owned subsidiaries located in Benelux, Brazil, Canada, France, Germany, Italy, Japan, Spain, Switzerland, and the UK. Certified by the International Organization for Standardization, Nova has manufacturing operations located in the U.S. and Taiwan. Our products include (click on an image or name for more on a specific product):
|
